Digital twins (DTs) in precision medicine are increasingly viable, propelled by extensive data collection and advancements in artificial intelligence (AI), alongside traditional biomedical methodologies. We argue that including mechanistic simulations that produce behavior based…
Continue Reading
Groundbreaking Collaboration Announcement
OMNY Health, a leading healthcare data monetization company, has established a strategic partnership with Scipher Medicine to advance precision medicine initiatives in immunology. This collaboration marks a significant milestone in healthcare data…
Mental health is shaped by socio-environmental determinants, yet traditional research approaches struggle to capture their complex interactions. This review explores the potential of generative agents, powered by large language models, to simulate human-like behaviour…
Continue Reading
Premature frailty is a critical challenge for young breast cancer survivors (YBCSs), impacting their health and perpetuating gender inequality through heightened vulnerability and marginalization. While digital health shows promise in frailty screening, its effectiveness…
Continue Reading
Electronic health records (EHRs) secondary usage with large language models (LLMs) raise privacy challenges. National regulations like GDPR and HIPAA offer protection frameworks, but specific strategies are needed to mitigate risk in generative AI….
Continue Reading
What You Should Know:
– Caris Life Sciences® (Caris), a pioneer in precision medicine and next-generation AI TechBio innovation, announced a transformative collaboration with Ontada®, a leading organization in oncology real-world evidence, clinical education, and point-of-care technologies.
– …
Continue Reading
Machine learning has increasingly been applied to predict opioid-related harms due to its ability to handle complex interactions and generating actionable predictions. This review evaluated the types and quality of ML methods in opioid…
Continue Reading
From AI-powered diagnostics to personalized medicine, we asked twenty four healthcare executives their insights on trends and technologies that will transform patient care in the coming year.
Ashley Barrow, Founder and CEO of RE-Assist
In 2025,…
Continue Reading
Can artificial intelligence improve clinical trial design? Despite their importance in medicine, over 40% of trials involve flawed protocols. We introduce and propose the development of application-specific language models (ASLMs) for clinical trial design…
Continue Reading
French medtech startup Robeauté has raised $28 million (£23m) to develop its microrobots which enter the brain to diagnose, treat and monitor neurological conditions.
The robots, which are the size of a grain of rice,…
